Speed
49 days to first decision for reviewed manuscripts only
43 days to first decision for all manuscripts 
84 days from submission to acceptance 
12 days from acceptance to publication

Infectious Agents and Cancer is an open access, peer-reviewed online journal that encompasses all aspects of basic, clinical, epidemiological and translational research providing an insight into the association between chronic infections and cancer.
The journal welcomes submissions in the pathogen-related cancer areas and other related topics pertinent to the development of therapies for chronic infections and cancer.
Of particular interest are HPV and anogenital cancers (as well as head and neck cancers), EBV and Burkitt lymphoma, HCV/HBV and hepatocellular carcinoma (as well as lymphoproliferative diseases), HHV8 and Kaposi sarcoma, HTLV and leukemia and Cancers in Low- and Middle-income countries.

Research article
Commentary
Hypothesis
Letter to the Editor
Meeting report
Methodology
Review
Short report

Editors-in-Chief 
Dr Franco M Buonaguro, Istituto Nazionale Tumori, Naples, Italy 
Dr Sam M Mbulaiteye, National Cancer Institute, Bethesda, USA
Managing Editor 
Dr Maria Lina Tornesello, Istituto Nazionale Tumori Fond Pascale IRCCS, Italy

Section Editors 

Clinical oncology
Prof Serigne Magueye Gueye, General Hospital of Grand-Yoff, Senegal 
Prof Jan Vermorken, University Hospital Antwerp, Belgium

African cancers 
Prof Twalib Ngoma, Ocean Road Cancer Institute, Tanzania 
Prof Henry R Wabinga, Makerere University, Uganda 

Cancer centers in low- and middle-income countries
Dr Kishor Bhatia, National Cancer Institute, USA 
Dr Edward Trimble, National Cancer Institute, USA 
Advisory Board 
Prof Peter Biberfeld, Karolinska Institute, Sweden 
Prof Luigi Chieco-Bianchi, University of Padova, Italy 
Prof Manfred P Dierich, Univeristät Innsbruck, Austria 
Prof Robert Gallo, University of Maryland, USA 
Prof Eva Klein, Karolinska Institute, Sweden 
Prof Bernard Roizman, University of Chicago, USA 
Prof Robin Weiss, University College London, UK 
Prof Dr Harald Zur Hausen, German Cancer Research Center, Germany 
Dr John Ziegler, University of California, San Francisco, USA
Editorial Board 
Dr Francisco Aguayo, University of Chile, Chile
Prof Niyaz Ahmed, University of Hyderabad, India 
Dr Adriana Albini, IRCCS Multimedica, Italy 
Prof Richard Ambinder, John Hopkins University, USA 
Prof Charles Bangham, Imperial College London, UK 
Dr Filippo Belardelli, Istituto Superiore di Sanità, Italy 
Prof Valerie Beral, University of Oxford, UK 
Prof Hans-Ulrich Bernard, University of California, Irvine, USA 
Prof Luigi Buonaguro, Istituto Nazionale Tumori, Italy
Prof Arséne Burny, University of Brussels, Belgium 
Prof Yuan Chang, University of Pittsburgh Cancer Institute, USA
Prof Massimo Clementi, Vita-Salute San Raffaele University, Italy 
Prof Pierre Coursaget, INSERM, France
Prof Ethel-Michele de Villiers, German Cancer Research Center, Germany 
Dr Riccardo Dolcetti, Centro di Riferimento Oncologico, Italy 
Prof Volker Erfle, Institute for Molecular Virology, Germany 
Prof Reza Farid, University of Mashhad, Iran 
Dr Silvia Franceschi, International Agency for Research on Cancer, France
Dr Renato Franco, University of Campania Luigi Vanvitelli, Italy 
Prof Niza Frenkel, Tel Aviv University, Israel 
Dr Denise DG Galloway, Fred Hutchinson Cancer Research Center, USA 
Dr Jean Marie Houghton, University of Massachusetts, USA
Prof Wenlin Huang, Sun Yat-sen University, China 
Prof Shuji Izumo, Kagoshima University, Japan 
Dr Steven Jacobson, Viral Immunology Section, National Institutes of Health, USA 
Prof Leo J Kinlen, University of Oxford, UK
Prof Andrei Kozlov, St Petersburg State University, Russia 
Prof Lucia Lopalco, San Raffaele Scientific Institute, Italy 
Prof Alberto Mantovani, University of Milan, Italy 
Dr Francesco Marincola, Sidra Medical and Research Center, USA
Prof Jay Nelson, Oregon Health & Sciences University, USA 
Prof Joseph S Pagano, University of North Carolina, USA
Prof Giorgio Palu, University of Padua, Italy 
Prof Yvonne Paterson, University of Pennsylvania, USA
Dr Maurizio Provenzano, University Hospital of Zurich, Switzerland
Dr Mihir S Rajurkar, Harvard Medical School, USA
Prof Thomas Schulz, University of Hannover, Germany
Prof Worachart Sirawaraporn, Mahidol University, Thailand 
Prof Freddy Sitas, The University of Sydney, Australia 
Dr Robert Yarchoan, HIV and AIDS Malignancy Branch, National Institutes of Health, USA